Larvol Delta - Bloom-Science-Completes-Enrollment-in-Phase-1-Trial-of-BL001-a-FirstinClass-Therapy-Being-Developed-for-Dravet-Syndrome

BL-001 - Bloom Science

https://www.prnewswire.com/news-releases/bloom-science-completes-enrollment-in-phase-1-trial-of-bl-001-a-first-in-class-therapy-being-developed-for-dravet-syndrome-301806574.html

Apr 25, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next